SV001

DRUG2 trials

Sponsors

Shanghai Synvida Biotechnology Co.,Ltd.

Conditions

Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis(IPF)

Early Phase 1

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.

RecruitingNCT06267183

Shanghai Synvida Biotechnology Co.,Ltd.Idiopathic Pulmonary Fibrosis

Start: 2024-01-12End: 2026-12-30Target: 53Updated: 2026-08-14

Phase 2

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis

RecruitingNCT07121413

Shanghai Synvida Biotechnology Co.,Ltd.Idiopathic Pulmonary Fibrosis(IPF)

Start: 2025-11-04End: 2026-12-31Target: 48Updated: 2026-02-11